InVitro International Reports Sales Growth, Sees Potential in Non-Animal Testing Technologies
TL;DR
InVitro International's FY '25 sales increase by 4.4%, signaling growth in Non-Animal test technologies for potential market advantage.
InVitro International, founded in 1985, utilizes non-animal testing methods to provide data on corrosivity and ocular/dermal irritation.
InVitro International's focus on non-animal testing methods contributes to the ethical advancement of technology, promoting regulatory acceptance of scientifically proven invitro test methods.
Canada and potentially the U.S.A. are moving towards banning animal-tested cosmetics, highlighting the global trend towards ethical testing methods.
Found this article helpful?
Share it with your network and spread the knowledge!
InVitro International (OTCQB: IVRO) reported first half fiscal year 2025 financial results, revealing sales of $440,650, representing a 4.4% increase compared to the same period in the previous fiscal year. Despite the sales growth, the company experienced a net income decline of 24.7%, dropping from $65,345 to $49,239.
CEO W. Richard Ulmer emphasized the company's optimism about the emerging landscape for non-animal testing technologies. Recent legislative developments in Canada and potential U.S. legislation signal a global shift away from animal testing, particularly in cosmetics and personal care products. Following Europe's 2013 ban on cosmetics developed using animal tests, congressional discussions are exploring extending similar restrictions to over-the-counter shampoos and skincare products.
The company's testing technologies focus on generating data about corrosivity and ocular/dermal irritation, providing scientifically validated alternatives to traditional animal testing methods. As regulatory agencies increasingly consider non-animal testing approaches, InVitro International is positioning itself at the forefront of this technological transition.
While the financial results show modest growth, the potential regulatory changes could significantly impact the company's future market positioning. The growing global momentum toward eliminating unnecessary animal testing presents substantial opportunities for non-animal testing technologies in various industries.
Curated from NewMediaWire
